bufexamac has been researched along with Acute Lung Injury in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, A; Dong, N; He, G; Huang, J; Huang, L; Li, J; Lu, W; Lu, Y; Mao, F; Wang, X; Wu, D; Xiao, Q; Xu, Y; Yang, G; Yao, X; Zhu, J | 1 |
1 other study(ies) available for bufexamac and Acute Lung Injury
Article | Year |
---|---|
Bufexamac ameliorates LPS-induced acute lung injury in mice by targeting LTA4H.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Bufexamac; Chemotaxis; Crystallography, X-Ray; Disease Models, Animal; Epoxide Hydrolases; Lipopolysaccharides; Mice; Neutrophils; Protein Binding; Protein Conformation | 2016 |